|
|
|
08/03/2010
Action Pharma reports positive results in a proof of concept phase IB study in obese human volunteers treated with small molecule oral once-daily AP1030 targeted for type II diabetes associated with obesity
 Read more »
11/02/2010
Frost & Sullivan Recognizes Doxa AB for Ceramir® Crown & Bridge, its Pioneering Biocompatible Dental Cement
Read more »
01/02/2010
Göran Beijer new CEO at ONCOlog Medical QA AB in Uppsala, Sweden
Read more »
29/01/2010
Siemens chooses ONCOlog Medical DIGNITY Carrier for PET/CT
Read more »
|
